The factor V activity test measures how well clotting factor V works in the blood. Factor V is one of the proteins that helps the body form a stable clot after injury. A normal result usually means factor V is present and functioning well enough for normal clot formation, while a low result points toward a bleeding-risk problem, a liver-related clotting problem, disseminated intravascular coagulation, an acquired inhibitor, or a rare inherited factor V deficiency. This test is not the same as testing for factor V Leiden, a genetic clotting-risk mutation that often occurs with normal factor V activity.
Factor V activity is usually reported as a percentage of normal pooled plasma. The exact reference range varies by laboratory, but many labs use a broad adult range near 50% to 200%, with some using narrower adult ranges such as about 64% to 166% or 70% to 165%. Your result needs interpretation with your symptoms, PT, aPTT, medications, liver tests, and bleeding history.
- A typical factor V activity normal range is about 50% to 200%, though each lab sets its own reference interval.
- Low factor V activity suggests reduced clotting ability and raises concern for bleeding, especially before surgery, after trauma, or during childbirth.
- Factor V deficiency is rare; severe inherited deficiency is often defined as activity below 1% of normal.
- Factor V activity is not the test for factor V Leiden; factor V Leiden is usually checked with activated protein C resistance testing or genetic testing.
- No fasting is usually needed, but anticoagulants and poor sample handling can distort the result.
- Urgent care is needed for heavy uncontrolled bleeding, black or bloody stool, vomiting blood, severe headache with neurologic symptoms, or major bleeding after injury.
Table of Contents
- What the Factor V Activity Test Measures
- Factor V Activity Normal Range
- How Factor V Activity Results Are Reported
- Why a Factor V Activity Test Is Ordered
- Low Factor V Activity: Causes and Meaning
- High Factor V Activity: Causes and Meaning
- Factor V Activity vs Factor V Leiden
- Preparation, Medications, and Sample Issues
- Follow-Up After an Abnormal Result
What the Factor V Activity Test Measures
The factor V activity test measures the working ability of clotting factor V in plasma, the liquid part of blood. It does not simply count how much factor V protein is present. It asks a more practical question: does the patient’s factor V help form a clot at the expected speed in a laboratory clotting system?
Factor V is part of the common pathway of coagulation. After blood vessel injury, factor V becomes activated factor Va. Activated factor V works with factor Xa, calcium, and phospholipid surfaces to convert prothrombin into thrombin. Thrombin then helps turn fibrinogen into fibrin, which strengthens the clot.
A factor V activity test is usually a clot-based assay. The laboratory mixes the patient’s plasma with plasma that lacks factor V but contains the other needed clotting factors. If the patient’s factor V works normally, the mixture clots in an expected time. If factor V is low or blocked by an inhibitor, clotting takes longer. The result is compared with normal plasma and reported as a percentage.
Factor V is sometimes called labile factor or proaccelerin. “Labile” means unstable. This matters because factor V activity drops when a blood sample is delayed, mishandled, repeatedly frozen and thawed, or stored incorrectly. A falsely low result is possible when specimen handling is poor.
Factor V is made mainly in the liver. A portion is also stored inside platelets and released when platelets activate. Because of that, factor V plays a role in both plasma-based clotting and the clot-forming environment around activated platelets.
This test often appears in a broader evaluation of abnormal clotting screens, such as a coagulation panel. It is especially helpful when both PT and aPTT are prolonged, since factor V sits in the shared part of the clotting pathway.
Factor V Activity Normal Range
A common factor V activity normal range is about 50% to 200% of the laboratory control or reference value. Some laboratories use narrower adult ranges, such as 64% to 166% or 70% to 165%. These differences are normal because laboratories use different reagents, instruments, calibration methods, and patient populations.
A result inside your lab’s stated reference range usually means factor V activity is adequate for normal clot formation. A mildly low value needs careful interpretation. A person with slightly reduced activity and no bleeding history often needs a different workup than a person with heavy menstrual bleeding, repeated nosebleeds, abnormal surgical bleeding, or a family history of a bleeding disorder.
| Factor V activity result | General meaning | Usual clinical concern |
|---|---|---|
| Within the lab range, often around 50% to 200% | Factor V activity is generally adequate | Factor V deficiency is unlikely if the sample was valid |
| Below the lab range but above 10% | Mild reduction | Bleeding risk varies; symptoms and surgery history matter |
| 1% to 10% | Moderate factor V deficiency range | Higher bleeding concern, especially with procedures or trauma |
| Less than 1% | Severe factor V deficiency range | Serious bleeding risk, including severe bleeding in infants or major bleeding events |
| Above the lab range | Increased activity | Usually less clinically useful than low activity; interpretation requires context |
The result should be read against the reference interval printed on the report. A value of 58% might be normal at one lab and slightly low at another. A value of 35% is usually low in adult testing, but the meaning still depends on why the test was ordered and whether the sample was reliable.
Factor V activity is often interpreted with other factor assays. For example, factor II, factor VII, and factor X activity help show whether a broader liver-related, vitamin K-related, warfarin-related, or consumption-related pattern exists. Comparing factor V with factor II activity is especially useful because factor II is vitamin K dependent, while factor V is not.
How Factor V Activity Results Are Reported
Factor V activity is usually reported as a percentage. A result of 100% means the sample behaves like normal reference plasma in that assay. A result of 50% means the sample shows about half of expected factor V activity. Some laboratories report results as IU/dL, which often tracks closely with percent activity in clinical use.
The report usually includes:
- The factor V activity result
- The laboratory reference range
- A flag such as low, normal, or high
- Sometimes a comment about anticoagulant interference, dilution testing, or specimen quality
A single number rarely tells the full story. Factor V activity belongs in a pattern. A clinician looks at the result with PT, INR, aPTT, thrombin time, fibrinogen, platelet count, liver enzymes, bilirubin, albumin, and signs of active bleeding or clotting.
A low factor V result with both prolonged PT and prolonged aPTT points toward a common pathway problem. A normal thrombin time helps separate factor V problems from fibrinogen problems or heparin contamination. A low factor V result with low fibrinogen and high D-dimer suggests consumption of clotting factors, such as disseminated intravascular coagulation. A low factor V result with liver failure signs suggests impaired liver synthesis.
Very low factor V activity deserves prompt attention, even when bleeding is not obvious. Some people with factor V inhibitors have severe laboratory abnormalities before major bleeding develops. Others bleed heavily after a trigger such as surgery, childbirth, dental work, trauma, or infection.
A mildly low result should not be ignored, but it also should not be treated as a diagnosis by itself. Repeat testing, mixing studies, and additional factor assays often clarify whether the result reflects a true deficiency, an inhibitor, medication interference, or a specimen problem. For a deeper look at abnormal low results, see low factor V activity.
Why a Factor V Activity Test Is Ordered
A factor V activity test is ordered when a clinician needs to explain abnormal clotting times, unusual bleeding, or a possible inherited or acquired clotting factor problem. It is not a routine screening test for healthy people.
Common reasons include:
- Prolonged PT and prolonged aPTT
- Unexplained bleeding after surgery, dental work, childbirth, or injury
- Frequent nosebleeds, gum bleeding, easy bruising, or heavy menstrual bleeding
- Suspected rare inherited factor V deficiency
- Suspected acquired factor V inhibitor
- Severe liver disease with abnormal clotting tests
- Disseminated intravascular coagulation or other factor consumption states
- Preoperative evaluation after abnormal clotting screens
- Family history of a rare bleeding disorder
- Follow-up of previously known factor V deficiency
The PT test checks clotting through the extrinsic and common pathways. The aPTT test checks clotting through the intrinsic and common pathways. Since factor V belongs to the common pathway, low factor V activity often prolongs both tests. A clinician evaluating prolonged clotting times often compares the result with the prothrombin time and the aPTT.
Factor V testing also helps separate similar-looking clotting problems. Vitamin K deficiency and warfarin treatment usually lower vitamin K-dependent factors, especially factors II, VII, IX, and X. Factor V is not vitamin K dependent, so a low factor V level points away from simple vitamin K deficiency and toward liver disease, consumption, inhibitor activity, inherited deficiency, or sample artifact.
The test is also useful when a patient has a bleeding history but standard tests do not explain the severity. Factor V deficiency is rare, so clinicians usually order this assay after more common causes have been considered.
Low Factor V Activity: Causes and Meaning
Low factor V activity means the plasma has less working factor V than expected. The main concern is bleeding, especially when factor V activity is very low or when another clotting problem is present at the same time.
Inherited factor V deficiency is rare and usually autosomal recessive, meaning a person often inherits disease-causing variants from both parents. It affects males and females. Symptoms range from mild bruising or nosebleeds to serious bleeding after surgery, childbirth, trauma, or in severe infant cases.
Acquired low factor V activity is more common than inherited severe deficiency in many clinical settings. It develops after birth due to another condition, medication effect, immune inhibitor, or sample problem.
Common causes include:
- Inherited factor V deficiency: A rare genetic condition also called Owren disease or parahemophilia.
- Acquired factor V inhibitor: An antibody blocks factor V function. This has been reported after surgery, exposure to certain topical thrombin or fibrin products, antibiotics, autoimmune disease, cancer, pregnancy, infection, and sometimes without a clear trigger.
- Severe liver disease: The liver produces factor V, so advanced liver dysfunction lowers factor V along with other clotting proteins.
- Disseminated intravascular coagulation: Clotting factors are consumed during widespread clotting and bleeding activation.
- Massive bleeding or dilution: Large-volume fluid or blood product resuscitation dilutes clotting factors.
- Combined factor V and factor VIII deficiency: A rare inherited disorder that lowers both factors.
- Medication or assay interference: Direct oral anticoagulants, heparin, and other anticoagulants can affect clot-based assays.
- Specimen handling problems: Factor V is unstable, so delayed processing or improper freezing can produce a falsely low result.
| Lab pattern | Possible explanation | Typical next step |
|---|---|---|
| Low factor V with prolonged PT and aPTT | Factor V deficiency, inhibitor, liver disease, or consumption | Review symptoms, medications, liver tests, fibrinogen, D-dimer, and mixing study |
| Low factor V with poor correction on mixing study | Possible inhibitor | Factor inhibitor testing and hematology consultation |
| Low factor V with low fibrinogen and high D-dimer | Possible disseminated intravascular coagulation or severe consumption | Urgent clinical evaluation and treatment of the underlying trigger |
| Low factor V with abnormal liver markers | Reduced liver synthesis | Liver disease assessment and bleeding-risk planning |
| Low factor V and low factor VIII | Possible combined factor V and factor VIII deficiency | Repeat factor assays and specialized hematology testing |
Bleeding symptoms do not always match the factor V percentage perfectly. Some people with low plasma factor V bleed less than expected because platelet factor V still contributes to clot formation. Others have major bleeding with acquired inhibitors or severe deficiency. History matters: a person who bled heavily after tooth extraction, surgery, childbirth, or trauma needs stronger follow-up than a person with no bleeding history and a borderline value.
A mixing study helps separate factor deficiency from an inhibitor. In this test, patient plasma is mixed with normal plasma. If clotting times correct, a deficiency is more likely. If clotting times do not correct, or correction fades after incubation, an inhibitor becomes more likely.
Factor V deficiency treatment focuses on bleeding control and procedure planning. There is no widely available factor V concentrate. Fresh frozen plasma is the usual replacement source for inherited deficiency when treatment is needed. Platelets also contain factor V and are sometimes used in severe bleeding or acquired inhibitor situations. Antifibrinolytic medicines are sometimes used for mucosal bleeding, such as nose or mouth bleeding, when appropriate.
Emergency care is needed for severe headache, confusion, weakness on one side, vision changes, heavy bleeding that does not stop, vomiting blood, black stool, major trauma, severe abdominal pain with bleeding signs, or heavy postpartum bleeding.
High Factor V Activity: Causes and Meaning
High factor V activity means the result is above the laboratory’s upper reference limit. This finding is usually less established and less actionable than low factor V activity. Unlike high factor VIII or high fibrinogen, high factor V is not commonly used as a standard clot-risk marker in routine thrombophilia evaluation.
A high result sometimes appears during inflammation, acute illness, pregnancy, estrogen exposure, metabolic stress, or after certain thrombotic events, but it does not diagnose a clotting disorder by itself. Laboratories and clinicians usually focus more on low factor V because low activity directly explains prolonged PT, prolonged aPTT, and bleeding risk.
High factor V activity should be interpreted cautiously because factor V testing is not designed as a stand-alone clot-risk screen. A person with a blood clot needs a clotting-risk evaluation based on the type of clot, age, provoking factors, family history, medications, cancer risk, antiphospholipid testing when appropriate, and inherited thrombophilia testing only when it changes management.
A high factor V activity result is also not the same as factor V Leiden. Many people with factor V Leiden have normal factor V activity. The problem in factor V Leiden is resistance to normal shutoff by activated protein C, not an excess amount of factor V activity on a standard activity assay.
For a more detailed interpretation of elevated values, see high factor V activity. In practice, repeat testing after recovery from illness and review of the full clotting picture often provide more useful information than reacting to one isolated high value.
Factor V Activity vs Factor V Leiden
Factor V activity testing and factor V Leiden testing answer different questions. Confusing them leads to incorrect assumptions about bleeding risk and clotting risk.
Factor V activity testing asks: Does factor V work well enough to support clot formation? Low activity points toward a bleeding-risk problem.
Factor V Leiden testing asks: Does the factor V gene carry a mutation that makes activated factor V harder to turn off? Factor V Leiden raises the risk of venous blood clots in some people, especially deep vein thrombosis and pulmonary embolism.
The standard factor V activity test does not diagnose factor V Leiden. A person with factor V Leiden often has normal factor V activity because the protein still works in clot formation. The issue is that activated protein C cannot inactivate it normally.
Factor V Leiden is usually evaluated with an activated protein C resistance test and, when needed, genetic testing. The activated protein C resistance test is the screening test most directly tied to factor V Leiden physiology.
This distinction matters because the conditions lead in opposite clinical directions:
- Low factor V activity usually raises concern for bleeding.
- Factor V Leiden usually raises concern for venous clotting.
- Normal factor V activity does not rule out factor V Leiden.
- Factor V Leiden does not explain prolonged PT and aPTT in the usual way.
- Factor V deficiency does not mean a person has factor V Leiden.
A patient with a personal or family history of blood clots should not assume a normal factor V activity result means thrombophilia testing is normal. Likewise, a patient with heavy bleeding should not assume factor V Leiden testing explains the bleeding.
Preparation, Medications, and Sample Issues
No fasting is usually required for a factor V activity test. Blood is drawn into a blue-top tube containing sodium citrate, an anticoagulant that preserves the sample for clotting tests. The tube must be filled correctly because the blood-to-citrate ratio affects clotting results.
Tell the ordering clinician and laboratory about all anticoagulants and antiplatelet medicines, including:
- Warfarin
- Heparin
- Low-molecular-weight heparin
- Apixaban
- Rivaroxaban
- Edoxaban
- Dabigatran
- Aspirin
- Clopidogrel
- Over-the-counter supplements that affect bleeding
Do not stop prescribed anticoagulants unless the clinician who manages them gives direct instructions. Stopping anticoagulation without a plan creates clot risk.
Anticoagulants can distort clot-based factor assays. Direct Xa inhibitors and direct thrombin inhibitors can produce falsely low clotting factor activity in some assay systems. Heparin contamination is also a concern, especially if blood is drawn from a heparinized line or from an arm with a heparin lock.
Specimen handling is unusually important for factor V because it is labile. Delayed processing, thawing during transport, repeated freeze-thaw cycles, clotted samples, hemolysis, underfilled citrate tubes, or dilution with IV fluid can make the result unreliable. When the result conflicts with the clinical picture, repeating the test from a clean peripheral draw is often the simplest first step.
A high hematocrit, usually above 55%, requires citrate adjustment in the collection tube. Without that adjustment, the plasma has too much citrate relative to plasma volume, which can prolong clotting times and affect factor assays.
Recent plasma transfusion also changes the result. Fresh frozen plasma contains factor V and can temporarily raise activity. Testing soon after transfusion may show treatment effect rather than the patient’s baseline level.
Follow-Up After an Abnormal Result
Follow-up depends on the degree of abnormality, bleeding symptoms, medications, and the rest of the clotting workup. Mild, unexpected abnormalities are often repeated. Markedly low activity, active bleeding, or an upcoming procedure needs faster review.
A typical follow-up plan includes:
- Confirm the result. Repeat testing is useful when the sample was delayed, drawn from a line, underfilled, thawed, or collected while anticoagulants were present.
- Review PT, INR, aPTT, thrombin time, fibrinogen, platelet count, D-dimer, and liver tests. The pattern often points toward liver disease, DIC, inhibitor activity, or isolated deficiency.
- Check other clotting factors. Factor II, VII, VIII, X, and fibrinogen results help define whether the problem is isolated or part of a broader disorder.
- Use a mixing study when PT or aPTT is prolonged. Correction supports deficiency; poor correction suggests inhibitor.
- Assess bleeding history. Surgery, dental extraction, childbirth, trauma, nosebleeds, gum bleeding, bruising, heavy menstrual bleeding, and family history all change the level of concern.
- Plan procedures carefully. Known factor V deficiency needs a bleeding prevention plan before surgery, invasive dental work, childbirth, biopsy, or major endoscopy.
- Refer to hematology when needed. Very low factor V activity, suspected inhibitor, repeated abnormal results, or clinically important bleeding deserves specialist input.
Low factor V from liver disease is treated differently from inherited deficiency. In liver disease, factor V reflects impaired synthetic function and does not correct with vitamin K the way vitamin K-dependent factors sometimes do. Treatment focuses on the liver condition, the bleeding situation, and the procedure risk.
Low factor V from DIC or severe consumption requires urgent treatment of the trigger, such as sepsis, trauma, obstetric complications, malignancy-related coagulation activation, or major shock. Plasma replacement alone does not solve the problem unless the underlying driver is addressed.
Inherited factor V deficiency requires education as well as treatment planning. Patients should tell surgeons, dentists, obstetric teams, and emergency clinicians about the diagnosis. Medical identification, a written hematology plan, and clear instructions for bleeding episodes reduce delays in urgent care.
A normal factor V result after an abnormal PT or aPTT does not end the evaluation. Other clotting factors, lupus anticoagulant, anticoagulant effects, fibrinogen disorders, platelet problems, or von Willebrand disease may still explain symptoms. Bleeding evaluation often requires several tests interpreted together rather than one isolated marker.
References
- Factor V assay: MedlinePlus Medical Encyclopedia 2025 (Official Patient Resource)
- Factor V deficiency: MedlinePlus Medical Encyclopedia 2024 (Official Patient Resource)
- Factor V Deficiency 2025 (Review)
- Rare inherited coagulation disorders: no longer orphan and neglected 2024 (Review)
- Diagnosis and management of the rare coagulation disorders: A UKHCDO Guideline on behalf of BCSH 2024 (Guideline)
- Acquired factor V inhibitor: a nation-wide study of 38 patients 2021 (Cohort Study)
Disclaimer
This article is for educational use and does not replace care from a qualified health professional. Factor V activity results need interpretation with your symptoms, medications, bleeding history, and other clotting tests. Seek urgent medical care for heavy bleeding, signs of internal bleeding, severe headache with neurologic symptoms, or major bleeding after injury.
